1. Koning M, Ailabouni R, Gearry RB, Frampton CM, Barclay ML. Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study. Inflamm Bowel Dis. 2013; 19:767–778. PMID:
23429459.
Article
2. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008; 14:542–549. PMID:
17941073.
Article
3. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012; 142:46–54. PMID:
22001864.
Article
4. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asiapacific Crohn's and colitis epidemiology study. Gastroenterology. 2013; 145:158–165. PMID:
23583432.
Article
5. Ye BD, Yang SK, Shin SJ, et al. Guidelines for the management of Crohn's disease. Korean J Gastroenterol. 2012; 59:141–179. PMID:
22387837.
Article
6. Choi CH, Kim YH, Kim YS, et al. Guidelines for the management of ulcerative colitis. Korean J Gastroenterol. 2012; 59:118–140. PMID:
22387836.
Article
7. Gisbert JP, Chaparro M. Vaccination strategies in patients with IBD. Nat Rev Gastroenterol Hepatol. 2013; 10:277–285. PMID:
23419290.
Article
8. Ananthakrishnan AN, McGinley EL. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohns Colitis. 2013; 7:107–112. PMID:
22440891.
Article
9. Stobaugh DJ, Deepak P, Ehrenpreis ED. Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample. Clin Exp Gastroenterol. 2013; 6:43–49. PMID:
23818801.
Article
10. Complementary, alternative, or integrative health: what's in a name?. National Center for Complementary and Alternative Medicine (NCCAM) [homepage on the Internet]. Maryland: NCCAM publication;updated 2013 May. cited 2008 October. Available from:
http://nccam.nih.gov/health/whatiscam/.
11. Langhorst J, Anthonisen IB, Steder-Neukamm U, et al. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use. Complement Ther Med. 2007; 15:30–37. PMID:
17352969.
Article
12. Ng SC, Lam YT, Tsoi KK, Chan FK, Sung JJ, Wu JC. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2013; 38:854–863. PMID:
23981095.
Article
13. Campins M, Cossio Y, Martinez X, Borruel N. Vaccination of patients with inflammatory bowel disease. Practical recommendations. Rev Esp Enferm Dig. 2013; 105:93–102. PMID:
23659508.
Article
14. Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010; 105:1231–1238. PMID:
20104218.
Article
15. Kotton CN. Vaccines and inflammatory bowel disease. Dig Dis. 2010; 28:525–535. PMID:
20926882.
Article
16. Melmed GY. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm Bowel Dis. 2009; 15:1410–1416. PMID:
19462435.
Article
17. Yun HS, Min YW, Chang DK, et al. Factors associated with vaccination among inflammatory bowel disease patients in Korea. Korean J Gastroenterol. 2013; 61:203–208. PMID:
23624734.
Article
18. Feuchtenberger M, Kleinert S, Schwab S, et al. Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study. Rheumatol Int. 2012; 32:1533–1539. PMID:
21327432.
Article
19. Parker S, Chambers White L, Spangler C, et al. A quality improvement project significantly increased the vaccination rate for immunosuppressed patients with IBD. Inflamm Bowel Dis. 2013; 19:1809–1814. PMID:
23714677.
Article
20. Chae BJ, Song BJ, Kim SS, et al. Use of complementary and alternative medicine by gastric cancer patients. J Korean Surg Soc. 2007; 72:369–378.